Log In
Print
BCIQ
Print
Print this Print this
 

ATIR (ATIR101)

Also known as: formerly Theralux-ATIR

  Manage Alerts
Collapse Summary General Information
Company Kiadis Pharma N.V.
DescriptionCell-based therapy containing mismatched donor lymphocytes depleted of alloreactive T cells
Molecular Target Not applicable
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Non-stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today